Integrated Diagnostics (UK) Today
| IDHC Stock | 0.44 0.01 2.22% |
Performance9 of 100
| Odds Of DistressLess than 2
|
Integrated Diagnostics is selling for under 0.44 as of the 24th of December 2024; that is 2.22 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.44. Integrated Diagnostics has a very small chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 24th of November 2024 and ending today, the 24th of December 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Integrated Diagnostics is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 581.33 M outstanding shares. More on Integrated Diagnostics Holdings
Moving against Integrated Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Integrated Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Integrated Diagnostics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Integrated Diagnostics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Care, Health Care Providers & Services, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
Integrated Diagnostics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Integrated Diagnostics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsIntegrated Diagnostics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Integrated Diagnostics' financial leverage. It provides some insight into what part of Integrated Diagnostics' total assets is financed by creditors.
| |||||
Integrated Diagnostics Holdings (IDHC) is traded on London Exchange in UK and employs 6,692 people. Integrated Diagnostics is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 26.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Integrated Diagnostics's market, we take the total number of its shares issued and multiply it by Integrated Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Integrated Diagnostics operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 581.33 M outstanding shares.
Integrated Diagnostics generates positive cash flow from operations, but has no cash available
Check Integrated Diagnostics Probability Of Bankruptcy
Ownership AllocationIntegrated Diagnostics Holdings has a total of 581.33 Million outstanding shares. Integrated Diagnostics secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Integrated Ownership Details
Integrated Diagnostics Risk Profiles
Although Integrated Diagnostics' alpha and beta are two of the key measurements used to evaluate Integrated Diagnostics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.86 | |||
| Semi Deviation | 2.88 | |||
| Standard Deviation | 3.82 | |||
| Variance | 14.61 |
Integrated Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Integrated Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Integrated Diagnostics Corporate Directors
| Sherif Zeiny | Group Director | Profile | |
| Tarek Yehia | Director Relations | Profile | |
| Nancy Fahmy | Investor Director | Profile | |
| Seham Ibrahim | Sales Director | Profile |
Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.